No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Cardiology
-
Cardiovascular Agents / therapeutic use*
-
England / epidemiology
-
Heart Failure* / diagnosis
-
Heart Failure* / drug therapy
-
Heart Failure* / epidemiology
-
Heart Failure* / etiology
-
Heart Failure* / mortality
-
Humans
-
Interdisciplinary Communication
-
Medical Audit
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Referral and Consultation
-
Risk Factors
-
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
-
Stroke Volume
-
United Kingdom / epidemiology
-
Wales / epidemiology
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Cardiovascular Agents
-
Mineralocorticoid Receptor Antagonists
-
Sodium Potassium Chloride Symporter Inhibitors